Chinese ophthalmology treatment firm Chaoju Eye Hospital Co. has completed a RMB400 million (US$59.17 million) series B round of financing, led by Orchid Asia Group and Riverhead Capital, according to a today’s statement.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
